×

Compounds to treat Alzheimer's disease

  • US 7,034,182 B2
  • Filed: 06/29/2001
  • Issued: 04/25/2006
  • Est. Priority Date: 06/30/2000
  • Status: Expired due to Fees
First Claim
Patent Images

1. A substituted amine of formula (XV) embedded imageor a salt thereof, where R1 is —

  • (CH2)n1

    (R1-aryl) where n1 is zero or one and where R1-aryl is phenyl, optionally substituted with one, two, or three of the following substituents (A) C1-C6 alkyl optionally substituted with one, two or three substituents selected from the group consisting of C1-C3 alkyl, —

    F, —

    Cl, —

    Br, —

    I, —

    OH, —

    SH, —

    C≡

    N, —

    CF3, C1-C3 alkoxy, and —

    NR1-aR1-b where R1-a and R1-b

    H or C1-C6 alkyl, (D) —

    F, Cl, —

    Br or —

    I, (F) —

    C1-C6 alkoxy optionally substituted with one, two, or three of;



    F, (G) —

    NRN-2RN-3 where RN-2 and RN-3 are as defined below, (H) —

    OH, (I) —

    C≡

    N, (K) —

    CO—

    (C1-C4 alkyl), where R2 is;



    H, or C1-C3 alkyl;

    where R3 is;



    H or C1-C3 alkyl;

    where RN is RN-1

    XN

    where XN is selected from the group consisting of;

    (A) —

    CO—

    , (B) —

    SO2

    , (C) —

    (CR′

    R″

    )1-6 where R′ and

    R″

    are the same or different and are —

    H or C1-C4 alkyl, (E) a single bond;

    where RN-1 is RN-aryl where RN-aryl is phenyl, 1-naphthyl, or 2-naphthyl, each of which is optionally substituted with one, two or three of the following substituents which can be the same or different and are;

    (1) C1-C6 alkyl, optionally substituted with one, two or three substituents selected from the group consisting of C1-C3 alkyl, —

    F, —

    Cl, —

    Br, —

    I, —

    OH, —

    SH, —

    C≡

    N, —

    CF3, C1-C3 alkoxy, and —

    NR1-aR1-b where R1-a and R1-b are as defined above, (2) —

    OH, (3) —

    NO2, (4) —

    F, —

    Cl, —

    Br, or —

    I, (5) —

    CO—

    OH, (6) —

    C≡

    N, (7) —

    (CH2)0-4

    CO—

    NRN-2RN-3 where RN-2 and RN-3 are the same or different and are selected from the group consisting of;

    (a) —

    H, (b) —

    C1-C6 alkyl optionally substituted with one substitutent selected from the group consisting of;

    (i) —

    OH, and (ii) —

    NH2, (c) —

    C1-C6 alkyl optionally substituted with one to three —

    F, —

    Cl, —

    Br, or —

    I, (d) —

    C3-C7 cycloalkyl, (e) —

    (C1-C2 alkyl)-(C3-C7 cycloalkyl), (f) —

    (C1-C6 alkyl)-O—

    (C1-C3 alkyl), (8) —

    (CH2)0-4

    CO—

    (C1-C12 alkyl), (11) —

    (CH2)0-4

    CO—

    (C3-C7 cycloalkyl), (15) —

    (CH2)0-4

    CO—

    RN-4 where RN-4 is selected from the group consisting of morpholinyl, thiomorpholinyl, piperazinyl, piperidinyl, homomorpholinyl, homothiomorpholinyl, homothiomorpholinyl S-oxide, homothiomorpholinyl S,S-dioxide, pyrrolinyl and pyrrolidinyl where each group is optionally substituted with one, two, three, or four of C1-C6 alkyl, (16) —

    (CH2)0-4

    CO—

    O—

    RN-5 where RN-5 is selected from the group consisting of;

    (a) C1-C6 alkyl, (b) —

    (CH2)0-2

    (R1-aryl) where R1-aryl is as defined above, (e) C3-C7 cycloalkyl, and (21) —

    (CH2)0-4

    N(H or RN-5)—

    CO—

    O—

    RN-5 where RN-5 can be the same or different (24) —

    (CH2)0-4

    N(—

    H or RN-5)—

    CO—

    RN-2 where RN-5 and RN-2 can be the same or different, (25) —

    (CH2)0-4

    NRN-2RN-3 where RN-2 and RN-3 can be the same or different, (26) —

    (CH2)0-4

    RN-4, (27) —

    (CH2)0-4

    O—

    CO—

    (C1-C6 alkyl), (29) —

    (CH2)0-4

    O—

    CO—

    N(RN-5)2, (31) —

    (CH2)0-4

    O—

    (RN-5)2 (34) —

    (CH2)0-4

    O—

    (C1-C6 alkyl optionally substituted with one, two, three, four, or five —

    F), (35) C3-C7 cycloalkyl, (39) —

    (CH2)0-4

    C3-C7 cycloalkyl, where RA is;

    (I) —

    C1-C10 alkyl optionally substituted with one, two or three substituents selected from the group consisting of C1-C3 alkyl, —

    F, —

    Cl, —

    Br, —

    I, —

    OH, —

    SH, —

    C≡

    N, —

    CF3, C1-C6 alkoxy, —

    O-phenyl, —

    NR1-aR1-b where R1-a and R1-b are as defined above, —

    OC═

    O NR1-aR1-b where R1-a and R1-b are as defined above, —

    S(═

    O)0-2 R1-a where R1-a is as defined above, —

    NR1-aC═

    O NR1-aR1-b where R1-a and R1-b are as defined above, —

    C═

    O NR1-aR1-b where R1-a and R1-b are as defined above, and —

    S(═

    O)2 NR1-aR1-b where R1-a and R1-b are as defined above, (III) —

    (CRA-xRA-y)0-4

    RA-aryl where RA-x and RA-y are (A) —

    H, (B) C1-C4 alkyl optionally substituted with one or two —

    OH, (C) C1-C4 alkoxy optionally substituted with one, two, or three of;



    F, (D) —

    (CH2)0-4

    C3-C7 cycloalkyl, (E) C2-C6 alkenyl containing one or two double bonds, (F) C2-C6 alkynyl containing one or two triple bonds, (G) phenyl, (IV) -cyclopentyl, -cyclohexyl, or -cycloheptyl ring fused to RA-aryl, where RA-aryl is as defined above where one carbon of cyclopentyl, cyclohexyl, or -cycloheptyl is optionally replaced with NH, NRN-5, O, or S(═

    O)0-2, and where cyclopentyl, cyclohexyl, or -cycloheptyl can be optionally substituted with one or two —

    C1-C3 alkyl, —

    F, —

    OH, —

    SH, —

    C≡

    N, —

    CF3, C1-C6 alkoxy, ═

    O, or —

    NR1-aR1-b where R1-a and R1-b are as defined above, (VI) —

    H, (VII) —

    C═

    OR7, wherein R7 is;

    C1-C6 alkyl, phenyl, (aryl)alkyl, cycloalkyl, cycloalkylalkyl, hydroxyalkyl, alkoxyalkyl, aryloxyalkyl, haloalkyl, carboxyalkyl, alkoxycarbonylalkyl, aminoalkyl, alkylaminoalkyl, dialkylaminoalkyl, lower alkenyl, where X is —

    N, or —

    O, with the proviso that when X is O, RB is absent;

    and when X is N, RB is;



    C1-C10 alkyl optionally substituted with one, two or three substituents selected from the group consisting of C1-C3 alkyl, —

    F, —

    Cl, —

    Br, —

    I, —

    OH, —

    SH, —

    C≡

    N, CF3, C1-C6 alkoxy, —

    O-phenyl, —

    NR1-aR1-b

    OC═

    O NR1-aR1-b

    C═

    O NR1-aR1-b where R1-a and R1-b are as defined above, and S(═

    O)2 NR1-aR1-b;

    (II) —

    (CH2)0-3

    (C3-C8) cycloalkyl where cycloalkyl can be optionally substituted with one, two or three substituents selected from the group consisting of C1-C3 alkyl, —

    F, —

    Cl, —

    Br, —

    I, —

    OH, —

    SH, —

    C≡

    N, —

    CF3, C1-C6 alkoxy, —

    O-phenyl, —

    CO—

    OH, —

    CO—

    O—

    (C1-C4 alkyl), and NR1-aR1-b;

    or —

    H.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×